Denosumab
Buyer: REGION HALLAND
- Published
- 27 March 2026
- Estimated value
- 9,000,000 kr
- Place of performance
- SE231
- Procedure
- Open procedure
- Lots
- 1
- Notice number
- 00214426-2026
- Reference
- 30bb4d03-6ac6-49b5-9143-a27bf970636e
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
Region Halland upphandlar sitt behov av denosumab i enlighet med bifogad sortimentsbilaga. Avtalet löper under en begränsad period till 2027-01-31 utan möjlighet till förlängning.
Award criteria
- Price — Lägst pris.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Amgen AB | 2,200,000 kr | — |
| Sandoz A/S | 1,650,000 kr | — |
| Gedeon Richter Nordics AB | 1,450,000 kr | — |
| Fresenius Kabi AB | 1,200,000 kr | — |
| Medical Valley Invest AB | 1,167,000 kr | — |
| Celltrion Sweden AB | 958,500 kr | — |
Official publications
- TED · 00214426-2026 · 27 March 2026
- OJS · 61/2026 · 27 March 2026
Other tenders from REGION HALLAND
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is 9,000,000 kr.
- Who is the buyer of this tender?
- The contracting authority is REGION HALLAND (European Union).
- How can I bid for public tenders in the European Union?
- Bids are submitted through the official public procurement portal in the European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the European Union that match your business, every day.
Create a free account and receive new public tenders published in the European Union that match your business, every day.